Electronically measured peak expiratory flow and FEV1 during respiratory symptoms in asthmatic childre

Completed

• Conditions: asthma; 10006436

• Registration Number: NL-OMON30426
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

- schoolchildren with dokters' diagnosed asthma, monitored by a pediatrician.
- age 6-16 year
- familiar with the outpatient asthma clinic in Zwolle
- capable of performing reproducible lung function measurements at home
- proper understanding of the dutch language
- informed consent

Exclusion Criteria

- other chronic or acute disease capable of influencing the study results
- airway tract infection or use of systemic corticosteroïds 4 weeks prior to the start of the study
- participation in another trial
- use of systemic corticosteroids and long-acting β2 sympathicomimetics.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>FEV1 and PEF when children have respiratory symptoms and take bronchodilators.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n/a</p><br>